Elizabeth Arden, Inc. (RDEN) Tops Q4 EPS by 8c; Guides FY12 EPS, Revs Growth
Tweet
Share
E-mailGet Alerts RDEN Hot Sheet
Price: $13.98 --0%
Financial Fact:
Total operating expenses: 106.39M
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Total operating expenses: 106.39M
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Elizabeth Arden, Inc. (NASDAQ: RDEN) reported Q4 EPS of $0.18, $0.08 better than the analyst estimate of $0.10. Revenue for the quarter came in at $253.8 million versus the consensus estimate of $242.82 million.
Elizabeth Arden, Inc. sees FY2012 EPS of $1.90-$2.00, versus the consensus of $1.91. Net sales are expected to increase by 5.0% to 6.0% over the prior fiscal year.
Elizabeth Arden, Inc. sees FY2012 EPS of $1.90-$2.00, versus the consensus of $1.91. Net sales are expected to increase by 5.0% to 6.0% over the prior fiscal year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Logistic Properties of the Americas (LPA) Reports Q2 results
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
